 |
 |
 |
 |
 |
 |
Set up in 2001, Photobiotics is a spin-out company from Imperial College, London, developing novel biologically-targeted photodynamic therapeutic (PDT) agents. Created out of a unique, in-house and world-class expertise in chemistry, physics, and biotechnology, these new PDT agents will be able to specifically target and destroy tumours, a range of other proliferating tissues, and pathogenic organisms. Applications of this new technology include cancer, age-related macular degeneration (AMD), 'irresistible antibiotics' and many more |
 |
